The next generation of rare disease drug policy: ensuring both innovation and affordability
Pearson C, Schapiro L, Pearson SD
Record ID 32018005197
English
Details
Project Status:
Completed
Year Published:
2022
URL for published report:
https://icer.org/wp-content/uploads/2022/04/ICER-White-Paper_The-Next-Generation-of-Rare-Disease-Drug-Policy_040722.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Rare Diseases
- Drug Costs
- Health Care Costs
- Health Policy
- Diffusion of Innovation
- Drug Approval
- Orphan Drug Production
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.